Cellebrite DI Q1 2024 Adj EPS $0.08 Beats $0.06 Estimate, Sales $89.582M Beat $87.757M Estimate
Cellebrite DI Q1 2024 Adj EPS $0.08 Beats $0.06 Estimate, Sales $89.582M Beat $87.757M Estimate
Cellebrite DI 2024年第一季度調整後每股收益0.08美元超過預期的0.06美元，銷售額8958.2萬美元超過8,7757萬美元的預期
Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.06 by 33.33 percent. This is a 166.67 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $89.582 million which beat the analyst consensus estimate of $87.757 million by 2.08 percent. This is a 25.76 percent increase over sales of $71.234 million the same period last year.
Cellebrite DI（納斯達克股票代碼：CLBT）公佈的季度收益爲每股0.08美元，比分析師普遍預期的0.06美元高出33.33％。這比去年同期每股收益0.03美元增長了166.67％。該公司公佈的季度銷售額爲8,958.2萬美元，比分析師普遍預期的8,7757萬美元高出2.08％。這比去年同期的7123.4萬美元銷售額增長了25.76％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。